Osteoporosis Clinical Trials

Osteoporosis is a disease in which bones become thin and weak causing them to break more easily. It is often called a "silent disease" because there are no symptoms; you can't feel your bones becoming weak. You may be at risk if you… Are over 50 years old Are postmenopausal ...

Currently looking for women who: Are 55 years or older and prescribed a daily or weekly medication for osteoporosis Have stopped using osteoporosis medication, or have not taken osteoporosis medication as prescribed by their doctor Are willing to participate in a 12-month study Your participation in a study could help ...

We are looking for postmenopausal women, 45 years of age or older, who have been diagnosed with osteoporosis to participate in a clinical research study. This study is currently enrolling, and will evaluate the safety and effectiveness of an investigational medication in reducing fractures due to osteoporosis. There is no ...

Currently we have the following studies: Birth Control/ Contraceptive Vaginal Atrophy Pain During Intercourse Dysplasia Endometriosis Pap Smear Mammogram Bone Density Osteoporosis Nocturia Uterine Fibroids Uterine Bleeding Post Menopausal Studies HPV STD Hot Flashes

Postmenopausal Osteoporosis is the medical term used for the disease that weakens bones in women, increasing the risk of sudden and unexpected fractures. Literally meaning "porous bone," osteoporosis results in an increased loss of bone mass and strength. The disease often progresses without any symptoms or pain. Many times, osteoporosis ...

The purpose of this study is to evaluate the safety of intravenous infusion of fucosylated autologous bone marrow cells as a new therapy in patients with established osteoporosis by a prospective, single-center, open, non-randomized and unblinded clinical trial.

Bisphosphonates (BP) are widely used in the prevention and treatment of osteoporosis in postmenopausal women and older men. Recently, there has been concern about the risk of adverse events after several years of using these agents. This has resulted in a publication from the Food and Drug Administration that suggested ...

Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement

The purpose of this study is to compare the safety and effectiveness of the SpineJack® with the Kyphx Xpander® Inflatable Bone Tamp and support a non-inferiority finding for the use of SpineJack® VCF treatment system versus Balloon Kyphoplasty.

Background: Type 2 diabetes may cause complications such as ischemic heart disease, nephropathy, neuropathy, and retinopathy. Several epidemiologic and animal studies also suggest that fracture risk is increased in diabetes. Bone is remodelled throughout life through bone resorption by the bone resorbing cells, the osteoclasts, and by bone formation by ...